Iwakuma T - Search Results

1

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.

Adhikari AS, Agarwal N, Wood BM, Porretta C, Ruiz B, Pochampally RR, Iwakuma T. Adhikari AS, et al. Among authors: iwakuma t. Cancer Res. 2010 Jun 1;70(11):4602-12. doi: 10.1158/0008-5472.CAN-09-3463. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460510 Free PMC article.

2

Metastatic potential of tumor-initiating cells in solid tumors.

Adhikari AS, Agarwal N, Iwakuma T. Adhikari AS, et al. Among authors: iwakuma t. Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1927-38. doi: 10.2741/3831. Front Biosci (Landmark Ed). 2011. PMID: 21196274 Free article. Review.

3

Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.

Adhikari AS, Iwakuma T. Adhikari AS, et al. Among authors: iwakuma t. Fukuoka Igaku Zasshi. 2009 Jun;100(6):217-28. Fukuoka Igaku Zasshi. 2009. PMID: 19670804 Free article. Review.

4

MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

Agarwal N, Adhikari AS, Iyer SV, Hekmatdoost K, Welch DR, Iwakuma T. Agarwal N, et al. Among authors: iwakuma t. Oncogene. 2013 Jan 24;32(4):462-70. doi: 10.1038/onc.2012.69. Epub 2012 Feb 27. Oncogene. 2013. PMID: 22370640 Free PMC article.

5

MDM2 binding protein, a novel metastasis suppressor.

Iwakuma T, Agarwal N. Iwakuma T, et al. Cancer Metastasis Rev. 2012 Dec;31(3-4):633-40. doi: 10.1007/s10555-012-9364-x. Cancer Metastasis Rev. 2012. PMID: 22684342 Review.

6

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.

Kundu AK, Iyer SV, Chandra S, Adhikari AS, Iwakuma T, Mandal TK. Kundu AK, et al. Among authors: iwakuma t. PLoS One. 2017 Jun 21;12(6):e0179168. doi: 10.1371/journal.pone.0179168. eCollection 2017. PLoS One. 2017. PMID: 28636657 Free PMC article.

7

MTBP plays a crucial role in mitotic progression and chromosome segregation.

Agarwal N, Tochigi Y, Adhikari AS, Cui S, Cui Y, Iwakuma T. Agarwal N, et al. Among authors: iwakuma t. Cell Death Differ. 2011 Jul;18(7):1208-19. doi: 10.1038/cdd.2010.189. Epub 2011 Jan 28. Cell Death Differ. 2011. PMID: 21274008 Free PMC article.

8

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.

Iyer SV, Parrales A, Begani P, Narkar A, Adhikari AS, Martinez LA, Iwakuma T. Iyer SV, et al. Among authors: iwakuma t. Oncotarget. 2016 Feb 2;7(5):5401-15. doi: 10.18632/oncotarget.6634. Oncotarget. 2016. PMID: 26700961 Free PMC article.

9

Mtbp haploinsufficiency in mice increases tumor metastasis.

Iwakuma T, Tochigi Y, Van Pelt CS, Caldwell LC, Terzian T, Parant JM, Chau GP, Koch JG, Eischen CM, Lozano G. Iwakuma T, et al. Oncogene. 2008 Mar 20;27(13):1813-20. doi: 10.1038/sj.onc.1210827. Epub 2007 Oct 1. Oncogene. 2008. PMID: 17906694

10

MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T. Bi Q, et al. Among authors: iwakuma t. Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11. Clin Exp Metastasis. 2015. PMID: 25759210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page